Sovereign Debt in Advanced Economies, and More from CRS
New and updated reports from the Congressional Research Service that Congress has withheld from online public distribution include the following.
Sovereign Debt in Advanced Economies: Overview and Issues for Congress, October 28, 2013
Foreign Assistance: Public-Private Partnerships (PPPs), October 28, 2013
Oil and Natural Gas Industry Tax Issues in the FY2014 Budget Proposal, October 30, 2013
Workforce Investment Act (WIA) Reauthorization Proposals in the 113th Congress: Comparison of Major Features of Current Law and S.1356, October 29, 2013
Automatic Continuing Resolutions: Background and Overview of Recent Proposals, October 28, 2013
The “Pay Ratio Provision” in the Dodd-Frank Act: Legislation to Repeal It in the 113th Congress, October 28, 2013
Armenia, Azerbaijan, and Georgia: Political Developments and Implications for U.S. Interests, October 25, 2013
Multiyear Procurement (MYP) and Block Buy Contracting in Defense Acquisition: Background and Issues for Congress, October 29, 2013
Yesterday, the U.S. Environmental Protection Agency proposed revoking its 2009 “endangerment finding” that greenhouse gases pose a substantial threat to the public. The Federation of American Scientists stands in strong opposition.
Modernizing ClinicalTrials.gov will empower patients, oncologists, and others to better understand what trials are available, where they are available, and their up-to-date eligibility criteria, using standardized search categories to make them more easily discoverable.
The Federation of American Scientists supports H.R. 4420, the Cool Corridors Act of 2025, which would reauthorize the Healthy Streets program through 2030 and seeks to increase green and other shade infrastructure in high-heat areas.
The current lack of public trust in AI risks inhibiting innovation and adoption of AI systems, meaning new methods will not be discovered and new benefits won’t be felt. A failure to uphold high standards in the technology we deploy will also place our nation at a strategic disadvantage compared to our competitors.